EP Patent

EP0748213A1 — Methods and compositions for pulmonary delivery of insulin

Assigned to Nektar Therapeutics · Expires 1996-12-18 · 29y expired

What this patent protects

Systemic delivery of insulin to a mammalian host is accomplished by inhalation of a dry powder of insulin. It has been found that dry insulin powders are rapidly absorbed through the alveolar regions of the lungs.

USPTO Abstract

Systemic delivery of insulin to a mammalian host is accomplished by inhalation of a dry powder of insulin. It has been found that dry insulin powders are rapidly absorbed through the alveolar regions of the lungs.

Drugs covered by this patent

Patent Metadata

Patent number
EP0748213A1
Jurisdiction
EP
Classification
—
Expires
1996-12-18
Drug substance claim
No
Drug product claim
No
Assignee
Nektar Therapeutics
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.